Side effects include amnesia, anxiety, discolored hair, dizziness, dry skin, hirsutism, hostility, impaired urination, paresthesia, penis disorder, peripheral edema, sweating, and vasodilation.
A synthetic anabolic steroid used for treating men with testosterone deficiency or similar androgen replacement therapies. Also, has antineoplastic properties and so has been used secondarily in women with advanced breast cancer. Methyltestosterone is a schedule III drug in the US.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Cyclosporine | The risk or severity of liver damage can be increased when Methyltestosterone is combined with Cyclosporine. |
| Dicoumarol | Methyltestosterone may increase the anticoagulant activities of Dicoumarol. |
| Phenindione | Methyltestosterone may increase the anticoagulant activities of Phenindione. |
| Coumarin | Methyltestosterone may increase the anticoagulant activities of Coumarin. |
| (R)-warfarin | Methyltestosterone may increase the anticoagulant activities of (R)-warfarin. |
| Tioclomarol | Methyltestosterone may increase the anticoagulant activities of Tioclomarol. |
| (S)-Warfarin | Methyltestosterone may increase the anticoagulant activities of (S)-Warfarin. |
| Phenprocoumon | Methyltestosterone may increase the anticoagulant activities of Phenprocoumon. |
| Acenocoumarol | Methyltestosterone may increase the anticoagulant activities of Acenocoumarol. |
| 4-hydroxycoumarin | Methyltestosterone may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Ethyl biscoumacetate | Methyltestosterone may increase the anticoagulant activities of Ethyl biscoumacetate. |
| Fluindione | Methyltestosterone may increase the anticoagulant activities of Fluindione. |
| Clorindione | Methyltestosterone may increase the anticoagulant activities of Clorindione. |
| Diphenadione | Methyltestosterone may increase the anticoagulant activities of Diphenadione. |
| Insulin human | Methyltestosterone may increase the hypoglycemic activities of Insulin human. |
| Insulin lispro | Methyltestosterone may increase the hypoglycemic activities of Insulin lispro. |
| Insulin glargine | Methyltestosterone may increase the hypoglycemic activities of Insulin glargine. |
| Insulin pork | Methyltestosterone may increase the hypoglycemic activities of Insulin pork. |
| Glimepiride | Methyltestosterone may increase the hypoglycemic activities of Glimepiride. |
| Sulfisoxazole | Methyltestosterone may increase the hypoglycemic activities of Sulfisoxazole. |
| Acetohexamide | Methyltestosterone may increase the hypoglycemic activities of Acetohexamide. |
| Miglitol | Methyltestosterone may increase the hypoglycemic activities of Miglitol. |
| Phenformin | Methyltestosterone may increase the hypoglycemic activities of Phenformin. |
| Gliclazide | Methyltestosterone may increase the hypoglycemic activities of Gliclazide. |
| Gliquidone | Methyltestosterone may increase the hypoglycemic activities of Gliquidone. |
| Mitiglinide | Methyltestosterone may increase the hypoglycemic activities of Mitiglinide. |
| Exenatide | Methyltestosterone may increase the hypoglycemic activities of Exenatide. |
| Mecasermin | Methyltestosterone may increase the hypoglycemic activities of Mecasermin. |
| Pramlintide | Methyltestosterone may increase the hypoglycemic activities of Pramlintide. |
| Glisoxepide | Methyltestosterone may increase the hypoglycemic activities of Glisoxepide. |
| Insulin aspart | Methyltestosterone may increase the hypoglycemic activities of Insulin aspart. |
| Insulin detemir | Methyltestosterone may increase the hypoglycemic activities of Insulin detemir. |
| Insulin glulisine | Methyltestosterone may increase the hypoglycemic activities of Insulin glulisine. |
| Glymidine | Methyltestosterone may increase the hypoglycemic activities of Glymidine. |
| AICA ribonucleotide | Methyltestosterone may increase the hypoglycemic activities of AICA ribonucleotide. |
| Buformin | Methyltestosterone may increase the hypoglycemic activities of Buformin. |
| Vildagliptin | Methyltestosterone may increase the hypoglycemic activities of Vildagliptin. |
| Voglibose | Methyltestosterone may increase the hypoglycemic activities of Voglibose. |
| NN344 | Methyltestosterone may increase the hypoglycemic activities of NN344. |
| AMG-222 | Methyltestosterone may increase the hypoglycemic activities of AMG-222. |
| Bisegliptin | Methyltestosterone may increase the hypoglycemic activities of Bisegliptin. |
| Liraglutide | Methyltestosterone may increase the hypoglycemic activities of Liraglutide. |
| Gosogliptin | Methyltestosterone may increase the hypoglycemic activities of Gosogliptin. |
| Glibornuride | Methyltestosterone may increase the hypoglycemic activities of Glibornuride. |
| Benfluorex | Methyltestosterone may increase the hypoglycemic activities of Benfluorex. |
| Albiglutide | Methyltestosterone may increase the hypoglycemic activities of Albiglutide. |
| Dulaglutide | Methyltestosterone may increase the hypoglycemic activities of Dulaglutide. |
| Insulin beef | Methyltestosterone may increase the hypoglycemic activities of Insulin beef. |
| Insulin degludec | Methyltestosterone may increase the hypoglycemic activities of Insulin degludec. |
| Insulin peglispro | Methyltestosterone may increase the hypoglycemic activities of Insulin peglispro. |
| Insulin tregopil | Methyltestosterone may increase the hypoglycemic activities of Insulin tregopil. |
| Ipragliflozin | Methyltestosterone may increase the hypoglycemic activities of Ipragliflozin. |
| Dutogliptin | Methyltestosterone may increase the hypoglycemic activities of Dutogliptin. |
| Allicin | Methyltestosterone may increase the hypoglycemic activities of Allicin. |
| Tofogliflozin | Methyltestosterone may increase the hypoglycemic activities of Tofogliflozin. |
| 2,4-thiazolidinedione | Methyltestosterone may increase the hypoglycemic activities of 2,4-thiazolidinedione. |
| Teneligliptin | Methyltestosterone may increase the hypoglycemic activities of Teneligliptin. |
| Omarigliptin | Methyltestosterone may increase the hypoglycemic activities of Omarigliptin. |
| Carmegliptin | Methyltestosterone may increase the hypoglycemic activities of Carmegliptin. |
| Gemigliptin | Methyltestosterone may increase the hypoglycemic activities of Gemigliptin. |
| Anagliptin | Methyltestosterone may increase the hypoglycemic activities of Anagliptin. |
| Evogliptin | Methyltestosterone may increase the hypoglycemic activities of Evogliptin. |
| Sotagliflozin | Methyltestosterone may increase the hypoglycemic activities of Sotagliflozin. |
| Remogliflozin etabonate | Methyltestosterone may increase the hypoglycemic activities of Remogliflozin etabonate. |
| Carbutamide | Methyltestosterone may increase the hypoglycemic activities of Carbutamide. |
| Guar gum | Methyltestosterone may increase the hypoglycemic activities of Guar gum. |
| Metahexamide | Methyltestosterone may increase the hypoglycemic activities of Metahexamide. |
| Semaglutide | Methyltestosterone may increase the hypoglycemic activities of Semaglutide. |
| Taspoglutide | Methyltestosterone may increase the hypoglycemic activities of Taspoglutide. |
| Englitazone | Methyltestosterone may increase the hypoglycemic activities of Englitazone. |
| Tirzepatide | Methyltestosterone may increase the hypoglycemic activities of Tirzepatide. |
| Gastric inhibitory polypeptide | Methyltestosterone may increase the hypoglycemic activities of Gastric inhibitory polypeptide. |
| Quinine | Methyltestosterone may increase the hypoglycemic activities of Quinine. |
| Mifepristone | Methyltestosterone may increase the hypoglycemic activities of Mifepristone. |
| Repaglinide | Methyltestosterone may increase the hypoglycemic activities of Repaglinide. |
| Glyburide | Methyltestosterone may increase the hypoglycemic activities of Glyburide. |
| Pioglitazone | Methyltestosterone may increase the hypoglycemic activities of Pioglitazone. |
| Bromocriptine | Methyltestosterone may increase the hypoglycemic activities of Bromocriptine. |
| Sunitinib | Methyltestosterone may increase the hypoglycemic activities of Sunitinib. |
| Lobeglitazone | Methyltestosterone may increase the hypoglycemic activities of Lobeglitazone. |
| Netoglitazone | Methyltestosterone may increase the hypoglycemic activities of Netoglitazone. |
| Rivoglitazone | Methyltestosterone may increase the hypoglycemic activities of Rivoglitazone. |
| Ciglitazone | Methyltestosterone may increase the hypoglycemic activities of Ciglitazone. |
| Balaglitazone | Methyltestosterone may increase the hypoglycemic activities of Balaglitazone. |
| Empagliflozin | Methyltestosterone may increase the hypoglycemic activities of Empagliflozin. |
| Acarbose | Methyltestosterone may increase the hypoglycemic activities of Acarbose. |
| Flunisolide | The risk or severity of edema formation can be increased when Methyltestosterone is combined with Flunisolide. |
| Beclomethasone dipropionate | The risk or severity of edema formation can be increased when Methyltestosterone is combined with Beclomethasone dipropionate. |
| Betamethasone | The risk or severity of edema formation can be increased when Methyltestosterone is combined with Betamethasone. |
| Fluticasone propionate | The risk or severity of edema formation can be increased when Methyltestosterone is combined with Fluticasone propionate. |
| Fluocinolone acetonide | The risk or severity of edema formation can be increased when Methyltestosterone is combined with Fluocinolone acetonide. |
| Triamcinolone | The risk or severity of edema formation can be increased when Methyltestosterone is combined with Triamcinolone. |
| Prednisone | The risk or severity of edema formation can be increased when Methyltestosterone is combined with Prednisone. |
| Fludrocortisone | The risk or severity of edema formation can be increased when Methyltestosterone is combined with Fludrocortisone. |
| Hydrocortisone | The risk or severity of edema formation can be increased when Methyltestosterone is combined with Hydrocortisone. |
| Prednisolone | The risk or severity of edema formation can be increased when Methyltestosterone is combined with Prednisolone. |
| Methylprednisolone | The risk or severity of edema formation can be increased when Methyltestosterone is combined with Methylprednisolone. |
| Trilostane | The risk or severity of edema formation can be increased when Methyltestosterone is combined with Trilostane. |
| Corticotropin | The risk or severity of edema formation can be increased when Methyltestosterone is combined with Corticotropin. |
| Cortisone acetate | The risk or severity of edema formation can be increased when Methyltestosterone is combined with Cortisone acetate. |